Акции Moderna взлетели на 160% на новостях об успехе вакцины против меланомы
· businessinsider.com
Moderna ищет свой следующий блокбастер после эпохи COVID, которая была чрезвычайно успешной.
After making its name as a vaccine-maker during the COVID era, Moderna has been looking for its second act as a major drug developer. Investors seem to think it...